4[1]Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease[J]. Endocri nl Metab Clin Nor Amer, 2001,30(2): 245-264.
5[2]Fatourechi V.Subclinical thyroid disease. Mayo Clin Proc,2001,76:413-417.
7Fekdt-Rasmussen U,schieusener H,Carayon P.Meta-analysis evaluation of tIIe impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves'disease[J].J Clin Endocrinol Metab,1994,78(1):98-102.
8Imura H,Fukata J,Moil T.Cytokines and endocrine function:an interaction between the immune and neuroendocrine systems[J].Clin Endocrinol(Oxf),1991,35(2):107-115.
9Wahrenberg H,Wennlund A,Hoffstedt J.Increased adipose tissue Becretion of interleukin-6,but not of leptin,plasminogen activator inhibitor-1 or tumour necrosis factor alpha,in Graves' hyperthyroidism[J].Eur J Endoerinol,2002,146(5):607-611.
